Viking Therapeutics VKTX
NASDAQ VKTX
$36.75 -4.90 (-11.76%)
At close: Sep 24, 2026 · 4:00 PM EDT

Viking Therapeutics (VKTX) Interest Coverage Ratio Growth (1y) (2015)

Analysis

Viking Therapeutics (VKTX) Interest Coverage Ratio Growth (1y) (2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover Growth (1y) (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 17.76%
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn -
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn -
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn -38.91%
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn -8.98%
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 36.43%
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn -532.04%
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn -
10 Viking Therapeutics 4.86 Bn 4.86 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2015 83.94%
API Access

Viking Therapeutics Interest Coverage Ratio Growth (1y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio-growth-1y&ticker=VKTX&period=max&api_key=YOUR_API_KEY